Back to results
US 9,790,519 B2Granted
Modified serotype 28 adenoviral vectors
AssigneeGenVec, Inc.
InventorsLisa Wei, Douglas E. Brough, C. Richter King
Life of this patent
Estimating the term…
Abstract
The invention provides a replication-deficient serotype 28 adenoviral vector characterized by comprising a portion of a serotype 45 adenoviral hexon protein and/or a portion of a serotype 45 fiber protein in place of the endogenous serotype 28 hexon and/or fiber protein.
Claims13
A replication-deficient serotype 28 adenoviral vector comprising chimeric hexon and fiber proteins selected from the group consisting of:
- (a) a chimeric hexon protein comprising a portion of an adenovirus serotype 45 hexon protein in place of a corresponding portion of the endogenous serotype 28 hexon protein, wherein the portion of adenovirus serotype 45 hexon protein consists of the amino acid sequence of SEQ ID NO:
- 1 or an amino acid sequence that is at least 95% identical to SEQ ID NO:
- 1;
- (b) a chimeric fiber protein comprising a portion of an adenovirus serotype 45 fiber protein in place of a corresponding portion of the endogenous serotype 28 fiber protein, wherein the portion of an adenovirus serotype 45 fiber protein consists of the amino acid sequence of SEQ ID NO:
- 3 or an amino acid sequence that is at least 95% identical to SEQ ID NO:
- 3;
- and
- (c) the chimeric hexon protein of (a) and the chimeric fiber protein of (b), wherein the adenoviral vector requires complementation of a deficiency in one or more early regions of the adenoviral genome for propagation and does not require complementation of any other deficiency of the adenoviral genome for propagation.
5 more elements
Dependencies are inferred from the claim text.